| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 13.31M | 10.92M | 12.31M | 8.70M | 6.55M | 7.82M |
| Gross Profit | 10.45M | 9.31M | 10.57M | 7.35M | 5.86M | 6.29M |
| EBITDA | 871.00K | 183.00K | 643.00K | -38.00K | -305.00K | 69.00K |
| Net Income | 414.00K | -158.00K | 309.00K | -338.00K | -642.00K | -322.00K |
Balance Sheet | ||||||
| Total Assets | 4.82M | 4.43M | 5.21M | 4.13M | 4.26M | 3.82M |
| Cash, Cash Equivalents and Short-Term Investments | 174.00K | 236.00K | 765.00K | 50.00K | 459.00K | 367.00K |
| Total Debt | 309.00K | 619.00K | 439.00K | 1.46M | 1.70M | 1.07M |
| Total Liabilities | 2.98M | 3.15M | 3.83M | 3.46M | 3.43M | 2.72M |
| Stockholders Equity | 1.84M | 1.28M | 1.38M | 670.00K | 836.00K | 1.11M |
Cash Flow | ||||||
| Free Cash Flow | 1.25M | -29.00K | 1.67M | -98.00K | -501.00K | 450.00K |
| Operating Cash Flow | 1.28M | 21.00K | 1.71M | -33.00K | -446.00K | 515.00K |
| Investing Cash Flow | -30.00K | -73.00K | -43.00K | -116.00K | -69.00K | -88.00K |
| Financing Cash Flow | -1.13M | -477.00K | -954.00K | -260.00K | 607.00K | -492.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
69 Neutral | £52.54M | 13.69 | 44.68% | ― | 1.44% | ― | |
68 Neutral | £11.93M | 6.75 | 23.32% | 6.54% | -6.12% | 4.30% | |
64 Neutral | £4.83M | 11.22 | 25.71% | ― | 17.91% | 73.21% | |
64 Neutral | £26.63M | 12.97 | 6.45% | 4.14% | 4.14% | -45.24% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
57 Neutral | £102.70M | -6.87 | -11.22% | 11.21% | -14.31% | -361.93% | |
49 Neutral | £16.09M | ― | -29.38% | ― | -1.70% | -29.90% |
Norman Broadbent reported strong financial performance in Q3 2025, with a 26% increase in net fee income (NFI) compared to Q3 2024, reaching £2.9 million. The company is optimistic about future growth, having completed a business turnaround and improved its financial position. It plans to invest in headcount for organic growth and explore strategic inorganic growth opportunities to scale its operations.
The most recent analyst rating on (GB:NBB) stock is a Hold with a £203.00 price target. To see the full list of analyst forecasts on Norman Broadbent stock, see the GB:NBB Stock Forecast page.
Norman Broadbent, a prominent executive search and interim management firm, has appointed Cooper Parry Group Limited as its new auditor following a formal tender process. This change comes as Kreston Reeves LLP, the outgoing auditor, resigns without any issues to report. The appointment of Cooper Parry is expected to be confirmed at the 2026 Annual General Meeting, potentially impacting the company’s financial oversight and stakeholder confidence.
The most recent analyst rating on (GB:NBB) stock is a Hold with a £203.00 price target. To see the full list of analyst forecasts on Norman Broadbent stock, see the GB:NBB Stock Forecast page.
Norman Broadbent reported a record interim financial performance for the first half of 2025, with significant growth in net fee income and underlying EBITDA. The company attributes its success to strategic investments in staff and a focus on operational efficiency, resulting in improved productivity and financial stability. The introduction of an AI-powered assessment tool and international hires in the US and UAE are expected to support further growth. The firm has successfully transformed its business, strengthened its market position, and improved its cash position, setting a strong foundation for future expansion.
The most recent analyst rating on (GB:NBB) stock is a Hold with a £203.00 price target. To see the full list of analyst forecasts on Norman Broadbent stock, see the GB:NBB Stock Forecast page.
Norman Broadbent plc, a leading executive search and interim management firm, announced it will release its interim results for the first half of 2025 on September 8, 2025. The company will host a virtual investor presentation and Q&A session on the same day, led by CEO Kevin Davidson and CFO Mehr Malik, providing stakeholders an opportunity to engage and inquire about the company’s performance and future outlook.
Norman Broadbent plc has appointed Cavendish Capital Markets Limited as its Nominated Adviser and Sole Corporate Broker. This strategic move is expected to enhance the company’s market operations and strengthen its industry positioning, potentially benefiting stakeholders through improved financial guidance and corporate brokerage services.